C

Chrysos Corp Ltd
ASX:C79

Watchlist Manager
Chrysos Corp Ltd
ASX:C79
Watchlist
Price: 7.95 AUD -0.38% Market Closed
Market Cap: AU$926m

Chrysos Corp Ltd
Investor Relations

Chrysos Corp Ltd is a AU-based company operating in Commercial Services & Supplies industry. The company is headquartered in Adelaide, South Australia. The company went IPO on 2022-05-06. Chrysos Corporation Limited is an Australia-based company, which provides gold testing technology. The firm is focused to combine science and software to create technology solutions for the global mining industry. The firm's flagship product, PhotonAssay provides quantitative data to all the mining exploration companies. PhotonAssay is an environmentally friendly replacement for fire assay on-site and in the laboratory. Its technology causes excitation of atomic nuclei allowing enhanced analysis of gold, silver, copper and other elements. The firm operates in Australia, North America and Africa.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q2 2025
Call Date
Jan 21, 2025
AI Summary
Q2 2025

Revenue Growth: Chrysos reported revenue of $15.3 million, up 53% year-on-year and 12% quarter-on-quarter, with significant growth outside Australia, especially in the Americas (up 305% YoY) and EMEA (up 42% YoY).

Record Sample Volumes: The company achieved its 25th consecutive quarter of record PhotonAssay sample volumes, up 53% year-on-year, indicating ongoing strong demand.

Strong Balance Sheet: Chrysos ended the quarter with $26.6 million in cash and an undrawn $95 million green loan, providing over $120 million available for growth investments.

Deployment Progress: 34 PhotonAssay units are now operating globally, after 3 new deployments this quarter. The total number of contracted units rose to 56.

Guidance Reaffirmed: Management confirmed FY '25 revenue guidance of $60–70 million and EBITDA guidance of $9–10 million.

Business Model Shift: The company continues shifting to direct contracts with miners, supported by an expanded sales team, while also maintaining strong relationships with major labs.

Cost Structure: Operating costs are becoming increasingly incremental, with most major team expansions now complete, supporting ongoing EBITDA improvement.

Key Financials
Revenue
$15.3 million
PhotonAssay Sample Volumes
record levels (25th consecutive quarter)
Cash
$26.6 million
Green Loan Facility
$95 million undrawn
PhotonAssay Units Deployed
34 units
Contracted Units
56 units
Available Funding
$121.6 million
Earnings Call Recording
Other Earnings Calls

Management

Mr. Robert Henry-Richard Adamson BE (Mech), BE Hons (Ag), MBA (AGSM)
Founder & Chairman
No Bio Available
Mr. Dirk Moore Treasure B.Sc., M.A.I.C.D.
MD, CEO & Executive Director
No Bio Available
Mr. Brett Anthony Coventry B.Acc. CPA, MBA
CFO & Joint Company Secretary
No Bio Available
Dr. James Tickner
Founder & CTO
No Bio Available
Dr. Alvin Chowles B.Sc., M.Sc., Ph.D.
Chief Operating Officer
No Bio Available
Ms. Kimberly Boland
Chief People Officer
No Bio Available
Mr. Anand Sundaraj BSc, LLB (Hon)
Joint Company Secretary
No Bio Available

Contacts

Address
SOUTH AUSTRALIA
Adelaide
Waite Road, Urrbrae, Gate 4
Contacts